Scotiabank initiated coverage on Tempest Therapeutics with a new price target

3/14/24 8:21:09 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Scotiabank initiated coverage of Tempest Therapeutics with a rating of Sector Outperform and set a new price target of $13.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TPST

Date	Price Target	Rating	Analyst
4/10/2025		Sector Outperform → Sector Perform	Scotiabank
4/10/2025		Buy → Neutral	H.C. Wainwright
3/14/2024	$13.00	Sector Outperform	Scotiabank
2/8/2024	$15.00	Buy	Jefferies
10/21/2021		Outperform	William Blair
7/13/2021	$51.00	Buy	HC Wainwright & Co.